Here, hyperoside was found to suppress SLC7A11 and GPX4 expression within CML cells while also altering the levels of ROS, Fe2+, MDA, NADPH, and GSH in these cells in a manner that could be reversed by inhibitors of ferroptosis. This evidence concerns the gene GPX4 and chronic myelogenous leukemia, BCR-ABL1 positive.